BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/7/2026 7:08:24 AM | Browse: 3 | Download: 0
 |
Received |
|
2025-07-02 01:39 |
|
Peer-Review Started |
|
2025-07-02 01:39 |
|
First Decision by Editorial Office Director |
|
2025-08-07 09:15 |
|
Return for Revision |
|
2025-08-07 09:15 |
|
Revised |
|
2025-08-16 07:14 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-24 02:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-25 06:32 |
|
Articles in Press |
|
2025-11-25 06:32 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-04 09:43 |
|
Publish the Manuscript Online |
|
2026-01-07 07:08 |
| ISSN |
2219-2824 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Minireviews |
| Article Title |
Preclinical pharmacology studies of zingerone with special reference to potential therapeutic applications
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Brahmjot Singh, Hasandeep Singh, Sarabjit Kaur and Balbir Singh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Balbir Singh, PhD, Professor, Department of Pharmaceutical Sciences, Guru Nanak Dev University, Grand Trunk Road, Off NH 1, Amritsar 143005, Punjab, India. balbir.pharma@gndu.ac.in |
| Key Words |
Zingerone; Anti-inflammation; Antioxidant; Anti-proliferative; Antidiabetic |
| Core Tip |
Zingerone is one of the potent natural bioactive molecules isolated from the ginger, a natural spice distributes all over the world. In this review, we have identified that zingerone possesses several pharmacological properties such as potent anti-oxidant, anti-inflammatory, anti-apoptotic, antiproliferative effects in pre-clinical studies. These properties suggest that the zingerone is more beneficial in curing several disorders. However, exploration of structure activity relationship could be useful to enhance its stability, safety and effectiveness. Thus, there is a need of future exploration for the therapeutic potential of zingerone in clinical studies. On the basis of literature reviews, it is concluded that zingerone possesses a great potential against various diseases. |
| Publish Date |
2026-01-07 07:08 |
| Citation |
Singh B, Singh H, Kaur S, Singh B. Preclinical pharmacology studies of zingerone with special reference to potential therapeutic applications. World J Immunol 2026; 16(1): 111511 |
| URL |
https://www.wjgnet.com/2219-2824/full/v16/i1/111511.htm |
| DOI |
https://dx.doi.org/10.5411/wji.v16.i1.111511 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
